Trials / Completed
CompletedNCT01897766
Special Investigation Of Genotropin Long Follow-Up For Patients With A Small For Gestational Age "Scoped for Japanese"
AN INVESTIGATION INTENDED TO EVALUATE THE LONG-TERM EFFICACY AND SAFETY OF GENOTROPIN IN CHILDREN WITH SGA DWARFISM WITHOUT EPIPHYSEAL CLOSURE. (RETROSPECTIVE STUDY)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 482 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 2 Years – 20 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this surveillance is to collect Safety and Effectiveness information for Long term Use of Somatropin for Patients with a Small for Gestational Age (SGA).
Detailed description
All the patients whom an investigator prescribes Genotropin should be registered consecutively until the number of subjects reaches target number in order to extract patients enrolled into the investigation at random.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Somatropin | 0.23 mg to 0.48 mg/kg/week |
Timeline
- Start date
- 2013-09-05
- Primary completion
- 2017-02-28
- Completion
- 2017-06-07
- First posted
- 2013-07-12
- Last updated
- 2023-09-25
- Results posted
- 2020-02-11
Source: ClinicalTrials.gov record NCT01897766. Inclusion in this directory is not an endorsement.